Inventor
ASHKENAZI AVI J
US45 patents
⚠️ This page may combine multiple inventors who share the name “ASHKENAZI AVI J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
40 patentsUS6342369B1Jan 29, 2002
Apo-2-receptor
GENENTECH INC127 citations99
US8030023B2Oct 4, 2011
Nucleic acid encoding DR5 antibodies and uses thereof
GENENTECH INC56 citations98
US6252050B1Jun 26, 2001
Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
GENENTECH INC149 citations98
US6030945AFeb 29, 2000
Apo-2 ligand
GENENTECH INC93 citations98
US5889155AMar 30, 1999
Carbohydrate-directed cross-linking reagents
GENENTECH INC83 citations97
US5329028AJul 12, 1994
Carbohydrate-directed cross-linking reagents
GENENTECH INC87 citations97
US6746668B2Jun 8, 2004
Apo-2 ligand
GENENTECH INC40 citations96
US6046048AApr 4, 2000
Apo-2 ligand
GENENTECH INC57 citations96
US8029783B2Oct 4, 2011
DR5 antibodies and articles of manufacture containing same
GENENTECH INC22 citations93
US7705195B2Apr 27, 2010
Screening method
GENENTECH INC47 citations93
US7314619B2Jan 1, 2008
Inducing apoptosis using anti-Apo-2 antibodies
GENENTECH INC18 citations93
US6998116B1Feb 14, 2006
Apo-2 ligand
GENENTECH INC22 citations93
US6469144B1Oct 22, 2002
Apo-2LI and Apo-3 polypeptides
GENENTECH INC19 citations93
US7390879B2Jun 24, 2008
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC36 citations92
US6582928B1Jun 24, 2003
Carbohydrate-directed cross-linking reagents
GENENTECH INC16 citations92
US7449176B2Nov 11, 2008
Treatment of inflammatory bowel disease with IFN-γ inhibitors
GENENTECH INC20 citations90
US7300656B2Nov 27, 2007
Treatment of inflammatory bowel disease with IFN-gamma inhibitors
GENENTECH INC23 citations90
US6558661B1May 6, 2003
Treatment of inflammatory bowel disease with IFN-γ inhibitors
GENENTECH INC33 citations90
US6764679B2Jul 20, 2004
Antibodies to DcR3 Polypeptide, a TNFR Homolog
GENENTECH INC38 citations89
US6740739B1May 25, 2004
Substitutional variants of APO-2 ligand
GENENTECH INC37 citations87
US7056736B2Jun 6, 2006
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC9 citations82
US6124435ASep 26, 2000
Carbohydrate-directed cross-linking reagents
GENENTECH INC10 citations82
US5929211AJul 27, 1999
Carbohydrate-directed cross-linking reagents
GENENTECH INC11 citations82
US7807153B2Oct 5, 2010
Apo-2 receptor agonist antibodies
GENENTECH INC4 citations74
US7595046B2Sep 29, 2009
Treatment of cancer using anti-Apo-2 antibodies
GENENTECH INC4 citations74
US7285533B2Oct 23, 2007
Apo-2 ligand
GENENTECH INC5 citations74
US7196165B2Mar 27, 2007
PRO363 polypeptides
GENENTECH INC6 citations74
US6462176B1Oct 8, 2002
Apo-3 polypeptide
GENENTECH INC12 citations74
US7592439B2Sep 22, 2009
Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
GENENTECH INC5 citations73
US5605791AFeb 25, 1997
Carbohydrate-directed cross-linking reagents
GENENTECH INC6 citations73
US6693181B2Feb 17, 2004
Protein secretion
GENENTECH INC7 citations72
US7629136B2Dec 8, 2009
Assays and methods using biomarkers
GENENTECH INC6 citations68
US7410772B2Aug 12, 2008
Compositions and methods for treatment of non-Hodgkin's lymphoma
GENENTECH INC2 citations58
US7939631B2May 10, 2011
APO-2 receptor polypeptides
GENENTECH INC0 citations52
US7749755B2Jul 6, 2010
Apo-2 receptor polynucleotides
GENENTECH INC0 citations52
US7750118B2Jul 6, 2010
Apo-2 receptor polypeptides
GENENTECH INC0 citations52
US7691978B2Apr 6, 2010
Antibodies that bind TAT294
GENENTECH INC0 citations52
US7547507B2Jun 16, 2009
Methods for the diagnosis of tumors
GENENTECH INC0 citations52
US7317092B2Jan 8, 2008
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC1 citations52
US7855066B1Dec 21, 2010
Methods for making Apo-2 ligand using divalent metal ions
GENENTECH INC0 citations37